CAHTALYST Trademark

Trademark Overview

On Friday, October 23, 2020, a trademark application was filed for CAHTALYST with the United States Patent and Trademark Office. The USPTO has given the CAHTALYST trademark a serial number of 90273954. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, October 23, 2024. This trademark is owned by Neurocrine Biosciences, Inc.. The CAHTALYST trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical information; excluding medical information in the field of ophthalmology

Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; all of the foregoing excluding use in the field of ophthalmology
cahtalyst

General Information

Serial Number90273954
Word MarkCAHTALYST
Filing DateFriday, October 23, 2020
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, October 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements

Pseudo MarkCATALYST
Goods and ServicesProviding medical information; excluding medical information in the field of ophthalmology
Goods and ServicesPharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; all of the foregoing excluding use in the field of ophthalmology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, December 12, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, December 12, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Tuesday, October 27, 2020NEW APPLICATION ENTERED
Saturday, December 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 15, 2020ASSIGNED TO EXAMINER
Wednesday, December 23, 2020NON-FINAL ACTION WRITTEN
Wednesday, December 23, 2020NON-FINAL ACTION E-MAILED
Wednesday, December 23, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 22, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 22, 2021SUSPENSION LETTER WRITTEN
Thursday, July 22, 2021LETTER OF SUSPENSION E-MAILED
Thursday, July 22, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, February 22, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, April 5, 2022SUSPENSION INQUIRY WRITTEN
Tuesday, April 5, 2022INQUIRY TO SUSPENSION E-MAILED
Tuesday, April 5, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, October 4, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, November 21, 2022ASSIGNED TO LIE
Monday, November 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 9, 2023ASSIGNED TO EXAMINER
Saturday, February 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 9, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 8, 2023SOU EXTENSION 1 FILED
Wednesday, November 8, 2023SOU EXTENSION 1 GRANTED
Friday, November 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 6, 2024SOU EXTENSION 2 GRANTED
Monday, May 6, 2024SOU EXTENSION 2 FILED
Monday, May 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 8, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 23, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 23, 2024SOU EXTENSION 3 GRANTED
Wednesday, October 23, 2024SOU EXTENSION 3 FILED
Thursday, March 20, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 20, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 20, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

cahtalyst pharmaceutical research clinical field trials medical information providing namely results